Results 281 to 290 of about 1,828,609 (409)

Shedding Light on the Cellular Uptake Mechanisms of Bioactive Glass Nanoparticles as Controlled Intracellular Delivery Platforms: A Review of the Recent Literature

Advanced Healthcare Materials, EarlyView.
This review summarizes the main uptake pathways of bioactive glass nanoparticles (BGNs) and their intracellular localization, highlighting that BGNs are mainly internalized and entrapped within endosomes/lysosomes. Strategies for controlled intracellular ion release, with implications for targeted modulation of cell behavior, are discussed. The need to
Andrada‐Ioana Damian‐Buda, Aldo R. Boccaccini   +1 more
wiley   +1 more source

Bilateral lateral ventricular epidermoid cyst: A case report. [PDF]

Int J Surg Case Rep
Asefa B, Zenebe E, Feleke E, Furi W, Solomon H.   +4 more
europepmc   +1 more source

Prevalence and natural history of arachnoid cysts in adults.

Journal of Neurosurgery, 2010
W. Al-Holou, Samuel W. Terman, Craig Kilburg, H. Garton, K. Muraszko, C. Maher   +5 more
semanticscholar   +1 more source

Magnetic Resonance Imaging‐Based Quantification of Endosomal Escape Using Iron Oxide Nanoparticle‐Loaded Lipid Nanoparticles

Advanced Healthcare Materials, EarlyView.
The therapeutic efficacy of lipid nanoparticle(LNP)‐based drugs depends on endosomal escape. However, few methods are available for quantifying the efficiency of endosomal escape in vivo. Herein, a novel method for quantifying the endosomal escape efficiency index using magnetic resonance imaging is introduced.
Somin Lee, Jeongbin Park, Han Na Jung, Shengjun Li, Zhijun Lin, Hyung‐Jun Im   +5 more
wiley   +1 more source

Primary Posterior Neck Hydatid Cyst: A Case Report and Review of the Literature. [PDF]

Case Rep Otolaryngol
Atwi G, Saad C, Serhal S, Saade R.
europepmc   +1 more source

Body Biofluids for Minimally‐Invasive Diagnostics: Insights, Challenges, Emerging Technologies, and Clinical Potential

Advanced Healthcare Materials, EarlyView.
Recent advances in diagnostics have accelerated the development of miniaturized wearable technologies for the continuous monitoring of diseases. This paradigm is shifting healthcare away from invasive, centralized blood tests toward decentralized monitoring, using alternative body biofluids.
Lanka Tata Rao, Chandan Kumar Mandal, Fernando Patolsky   +2 more
wiley   +1 more source

Bilateral Spontaneous Pneumothorax in a Young Gentleman. [PDF]

Respirol Case Rep
Teng A, Chua TH, Chow CY, Tan YH.
europepmc   +1 more source

A Method of Concentrating Entamœba Cysts in Stools.

, 1917
Hubert M. Turnbull
openalex   +1 more source

miRNA Biomarkers in Cyst Fluid Augment the Diagnosis and Management of Pancreatic Cysts

Clinical Cancer Research, 2012
H. Matthaei, D. Wylie, M. Lloyd, Marco dal Molin, Jon Kemppainen, S. Mayo, elliot k fishman, R. Schulick, Laura Langfield, B. Andruss, A. Adai, R. Hruban, A. E. Szafranska-Schwarzbach, A. Maitra   +13 more
semanticscholar   +1 more source

Harnessing Next‐Generation 3D Cancer Models to Elucidate Tumor‐Microbiome Crosstalk

Advanced Healthcare Materials, EarlyView.
Centralizes the microbiome within 3D tumor‐microbiome model platforms, including spheroids, organoids, 3D‐bioprinted constructs, and microfluidic chips, each enabling structured host‐tumor‐microbe studies. These systems support bacterial colonization, facilitating investigation of microbial impacts on tumor growth, immunity, and therapy. The microbiome
Marina Green Buzhor, Giuseppe Longobardi, Or Kandli, Anne Krinsky, Opal Avramoff, Anshika Katyal, Koren Salomon, Adan Miari, Dana Venkert, Tania T. Barnatan, América García Alvarado, Shahar Greenberg, Ronit Satchi‐Fainaro   +12 more
wiley   +1 more source